Axon Enterprise, Inc. (NASDAQ:AXON) Stake Boosted by SYSTM Wealth Solutions LLC

SYSTM Wealth Solutions LLC increased its holdings in Axon Enterprise, Inc. (NASDAQ:AXON) by 86.1% in the second quarter, HoldingsChannel.com reports. The institutional investor owned 3,844 shares of the biotechnology company’s stock after purchasing an additional 1,778 shares during the quarter. SYSTM Wealth Solutions LLC’s holdings in Axon Enterprise were worth $1,131,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. ING Groep NV grew its holdings in Axon Enterprise by 9.3% in the 4th quarter. ING Groep NV now owns 9,643 shares of the biotechnology company’s stock worth $2,491,000 after buying an additional 821 shares in the last quarter. Avantax Advisory Services Inc. grew its holdings in Axon Enterprise by 0.8% in the 1st quarter. Avantax Advisory Services Inc. now owns 5,302 shares of the biotechnology company’s stock worth $1,659,000 after buying an additional 40 shares in the last quarter. GSA Capital Partners LLP bought a new position in Axon Enterprise in the 1st quarter worth approximately $931,000. Sumitomo Mitsui Trust Holdings Inc. grew its holdings in Axon Enterprise by 14.8% in the 1st quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 170,376 shares of the biotechnology company’s stock worth $53,307,000 after buying an additional 22,013 shares in the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in Axon Enterprise by 21.7% in the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 9,153 shares of the biotechnology company’s stock worth $2,693,000 after buying an additional 1,634 shares in the last quarter. 79.08% of the stock is owned by institutional investors.

Axon Enterprise Price Performance

AXON opened at $382.57 on Wednesday. The stock has a fifty day moving average of $340.58 and a 200-day moving average of $315.24. The firm has a market capitalization of $28.87 billion, a P/E ratio of 111.86, a PEG ratio of 10.30 and a beta of 0.94. Axon Enterprise, Inc. has a 12-month low of $189.12 and a 12-month high of $386.54. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The business had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. During the same period in the prior year, the business posted $0.80 earnings per share. Axon Enterprise’s revenue for the quarter was up 34.5% compared to the same quarter last year. Equities analysts forecast that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on the company. JMP Securities upped their target price on Axon Enterprise from $375.00 to $430.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. Needham & Company LLC restated a “buy” rating and issued a $400.00 target price on shares of Axon Enterprise in a research report on Wednesday, August 7th. Northland Securities upped their target price on Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research report on Thursday, August 8th. Jefferies Financial Group assumed coverage on Axon Enterprise in a research report on Wednesday, July 17th. They issued a “buy” rating and a $385.00 target price for the company. Finally, Bank of America assumed coverage on Axon Enterprise in a research report on Wednesday, July 17th. They issued a “buy” rating and a $380.00 target price for the company. Two analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $365.38.

Insider Transactions at Axon Enterprise

In other news, Director Michael Garnreiter sold 1,000 shares of the company’s stock in a transaction on Monday, September 16th. The shares were sold at an average price of $380.99, for a total value of $380,990.00. Following the transaction, the director now directly owns 27,259 shares of the company’s stock, valued at $10,385,406.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the stock in a transaction on Monday, September 16th. The shares were sold at an average price of $380.99, for a total transaction of $380,990.00. Following the transaction, the director now directly owns 27,259 shares of the company’s stock, valued at $10,385,406.41. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Patrick W. Smith sold 80,300 shares of the stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $371.78, for a total transaction of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 317,981 shares of company stock valued at $115,662,734. 6.10% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.